Trial Profile
Determining the effects of risperidal Consta in patients with psychotic disorders and incomplete adherence.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2014
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 01 Mar 2012 Actual patient number (64) added as reported by ClinicalTrials.gov.
- 01 Mar 2012 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
- 25 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.